Paul W. Ewald

PhD

Most Recent Articles by Paul W. Ewald

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

CAR T Cell Therapy for Acute Lymphoblastic Leukemia Recommended by FDA

By

The FDA recommended the approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL).

Sign Up for Free e-Newsletters